Chronic necrotizing pulmonary aspergillosis complicated by a cavitary lesion caused by pulmonary Mycobacterium-avium complex disease

Internal Medicine

Volumn 44, Issue 3, 2005, Pages 246-250

  Kobashi, Yoshihiro ^a   Yoshida, Kouichiro ^a   Miyashita, Naoyuki ^a   Niki, Yoshihito ^a   Matsushima, Toshiharu ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Cavitary lesion; Chronic necrotizing pulmonary aspergillosis; Pulmonary nontuberculous mycobacterial disease

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CLARITHROMYCIN; ETHAMBUTOL; FUNGUS ANTIBODY; ITRACONAZOLE; LEVOFLOXACIN; MICAFUNGIN; RIFAMPICIN; STREPTOMYCIN;

AGED; ARTICLE; ASPERGILLUS NIGER; ATYPICAL MYCOBACTERIOSIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; FEMALE; FEVER; FUNGUS ISOLATION; HOSPITAL ADMISSION; HUMAN; LUNG ASPERGILLOSIS; MYCETOMA; MYCOBACTERIUM INTRACELLULARE AVIUM; SPUTUM ANALYSIS; SYMPTOM; THORAX RADIOGRAPHY; TREATMENT FAILURE;

AGED; ANTI-BACTERIAL AGENTS; ANTIBODIES, FUNGAL; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS NIGER; CHRONIC DISEASE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG DISEASES, FUNGAL; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; NECROSIS; RADIOGRAPHY, THORACIC; SPUTUM; TOMOGRAPHY, X-RAY COMPUTED;

EID: 17744367244     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.44.246     Document Type: Article

References (22)

1. Alan MS, Elizabeth AO. Aspergillus syndrome, mucormycosis and pulmonary candidiasis. in: Fisherman's Pulmonary Disease and Disorders 3rd edition. McGraw-Hill, NY, 1998: 2265-2268.
2. Kawamura S, Maesaki S, Tomono K, Tashiro T, Kohno S. Clinical evaluation of 61 patients with pulmonary aspergilloma. Intern Med 39 209-212, 2000.
3. American Thoracic Society. Diagnosis and treatment of disease caused by non-tuberculous mycobacteria. Medical Section of the American Lung Association. Am J Respir Crit Care Med 156: S1-S25, 1997.
4. Ortbals DW, Marr JJ. A comparative study of tuberculosis and other mycobacterial infections associated with malignancy. Am Rev Respir Dis 117: 39-45, 1978.
5. Tanaka E, Amitani R, Kuze F. Clinical features of the patients with "secondary infection" of Mycobacterium avium complex. Radiographic pattern of progressions in the patients with and without underlying pulmonary conditions. Kekkaku 68: 57-61, 1993 (in Japanese, Abstract in English).
6. Fraser RS, Müller NL, Coleman N, et al. Diagnosis of Diseases of the Chest. 4th ed, WB Saunders, NY, 1999: 875-978.
7. Massard G, Roeslin N, Wihlm JM, Dumont P, Witz JP, Morand G. Pleuropulmonary aspergilloma: clinical spectrum and results of surgical treatment. Ann Thorac Surg 54: 1159-1164, 1992.
8. Chatzimichalis A, Massard G, Kessler R, et al. Pleuropulmonary aspergilloma: A reappraisal. Ann Thorac Surg 65: 927-929, 1998.
9. Johnston ID. Mycobacterium xenopi infection and aspergilloma. Tubercle 69: 139-143, 1988.
10. Choudat D, Horreard P, Pretet S, Grosset J, Toty L. Superinfection by Aspergillus fumigatus of a pulmonary lesion caused by Mycobacterium xenopi. Tubercle 67: 71-74, 1986.
11. Gefter WB, Weingrad TR, Epstein DM, Ochs RH, Miller WT. "Semi-invasive" pulmonary aspergillosis: a new look at the spectrum of aspergillus infections of the lung. Radiology 140: 313-321, 1981.
12. Binder RE, Faling LJ, Pugatch RD, Mahasaen C, Snider GI. Chronic necrotizing pulmonary aspergillosis: a discrete clinical entity. Medicine (Baltimore) 61: 109-124, 1982.
13. Denning DW. Chronic forms of pulmonary aspergillosis. Clin Microbiol Infect 7: 25-31, 2001.
14. Perfect JR, Cox JY, Lee CA, et al. The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis 33: 1824-1833, 2001.
15. Takayama S, Kataoka N, Usui Y, et al. CA 19-9 in patients with benign pulmonary diseases. Nippon Kyoubu Shikkan Gakkai Zasshi 28 1326-1331, 1990 (in Japanese, Abstract in English).
16. Ichiki H, Shishido M, Nishitani K, et al. Evaluation of CEA, SLX and CA125 in active pulmonary tuberculosis. Nippon Kyoubu Shikkan Gakkai Zasshi 31: 1522-1527, 1993.
17. Matsuoka Y, Endo K, Kawamura Y, et al. Normal bronchial mucous contains high levels of cancer-associated antigens, CA125, CA19-9, and carcinoembryonic antigen. Cancer 65: 506-510, 1990.
18. Kobashi Y, Matsushima T. The effect of combined therapy according to the guidelines for the treatment of Mycobacterium avium complex pulmonary disease. Intern Med 42: 670-675, 2003.
19. Stevens DA, Bennett JE. Chapter 35. Antifungal agents, basic principles. in: The Diagnosis and Management of Infecfious Diseases. 5th ed, NY, Churchill Livingstone, 2000.
20. Arathoon EG. Clinical efficacy of echinocandin antifungals. Curr Opin Infect Dis 14: 685-691, 2001.
21. Yamada H, Kohno S, Koga H, Maesaki S, Kaku M. Topical treatment of pulmonary aspergilloma by antifungals. Relationship between duration of the disease and efficacy of therapy. Chest 103: 1421-1425, 1993.
22. Lee KS, Kim YH, Bae WK. Percutaneous intracavitary treatment of a giant aspergilloma. Am J Roentogenol 154: 1346, 1990.